Introduction
The number of tuberculosis patients infected with multidrug-resistant strains is on the rise, and particularly in the developing countries; this is largely due to the failure of control programs to provide adequate treatment and it is also due to the markedly increased prevalence of this disease in certain high-risk groups. Multidrug-resistant tuberculosis is associated with higher rates of treat-ment failure and death than is drug-susceptible tuberculosis, and these resistant strains are is more difficult and expensive to treat 1,2 . In 1995, the federal and local governments of the Russian Federation implemented a pilot project to reverse a trend for the increasing incidence of tuberculosis by using the World Health Organization (WHO) tuberculosis control strategy of direct observed therapy, the short course (DOTS), in the city of Ivanovo in Oblast 3 . Despite implementation of the DOTS program, poor treatment outcomes were reported; primary multidrug-resistant tuberculosis (P-MDRTB), defined as Mycobacterium tuberculosis isolates resistant to at least isoniazid and rifampin in never-been-treated tuberculosis patients, was suspected to be a major contributing factor. P-MDRTB is caused by the transmission of a resistant strain from one patient, who was infected with a resistant M. tuberculosis strain, to another patient 4 .
A recent summary of antituberculosis drug resistance surveys conducted in 58 countries showed that multidrug-resistant tuberculosis continues to be a serious problem 5 . During the period between 1994 and 1998 in the Republic of Korea, where tuberculosis-control programs have been conducted for many years, there were statistically significant decreases in the prevalence of resistance to at least one drug among the previously treated cases. On the other hand, the prevalence of P-MDRTB slightly increased. Although there were no significant increases in the prevalence of P-MDRTB in most countries, the high prevalence of this malady that's been observed in some countries warrants international attention because the movement of people from country to country may lead to an increase of the prevalence of primary multidrug-resistance.
Until recently, there have been few studies on risk factors for P-MDRTB. The present case-control study was conducted to identify risk factors for P-MDRTB.
Materials and Methods
The study was conducted at National Masan 
Discussion
To the best of our knowledge, this is the first report on the factors that are associated with P-MD-RTB in the patient background of a low prevalence of HIV. The proportion of HIV-positive cases in all the tuberculosis patients is as low as 1.0% in the Republic of Korea 6 . Our study found that patients who had P-MDRTB were statistically more likely to have diabetes mellitus. There have been several previous studies on the relationship between diabetes mellitus and tuberculosis. Individuals with diabetes mellitus have a 2.0 to 3.6 fold increased incidence of tuberculosis compared to nondiabetics 7, 8 . Furthermore, diabetics may present with more advanced disease at the time of the tuberculosis diagnosis and they may have an increased mortality rate 9 . In terms of the relationship between multidrug-resistant tuberculosis and diabetes mellitus, it was reported that there was an increased incidence of multidrug-resistant tuberculosis in diabetic patients 10 . The mechanisms that may predispose the diabetic patient to lower respiratory tract infection are not completely understood. The excess morbidity and mortality may be related in part to specific diabetes-associated host immune defects as well as an increased risk that is due to coexisting conditions such as malnutrition, vascular insufficiency, cardiovascular disease and chronic renal disease [11] [12] [13] [14] .
Unexpectedly, we found that smoking was inversely associated with having P-MDRTB, even though there are no confirmative evidences for any kind of relationship between smoking and P-MDRTB. It is possible that the patients' general condition was poorer for the P-MDRTB patients than it was for the controls; therefore the case patients were less likely to smoke. However, detailed information on smoking such as past smoking history was not obtained, and so we could not fully explain this finding. Even though age was not independently associated with P-MDRTB in this study, younger peoples were more likely to have P-MDRTB. There is concern that the patients with P-MD-RTB might rapidly increase in many developing countries in which the incidence of tuberculosis is high and the incidence of chronic diseases such as diabetes mellitus is sky-rocketing. 
